相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-27 enhances the survival of tumor antigen-specific CD8+T cells and programs them into IL-10-producing, memory precursor-like effector cells
Zhenzhen Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
C. Andrew Stewart et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
Michael A. Curran et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
Takashi Tanikawa et al.
CANCER RESEARCH (2012)
IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without De Novo Infiltration from Secondary Lymphoid Organs
Jan Emmerich et al.
CANCER RESEARCH (2012)
IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
John B. Mumm et al.
CANCER CELL (2011)
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Cailin Moira Wilke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3- and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
Samuel Huber et al.
IMMUNITY (2011)
An Interleukin-21-Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells
Weiguo Cui et al.
IMMUNITY (2011)
Highly Activated Cytotoxic CD8 T Cells Express Protective IL-10 at the Peak of Coronavirus-Induced Encephalitis
Kathryn Trandem et al.
JOURNAL OF IMMUNOLOGY (2011)
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
Rao H. Prabhala et al.
BLOOD (2010)
Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy
Lixin Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Regulatory T cells in tumor immunity
Hiroyoshi Nishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells
Xinming Su et al.
JOURNAL OF IMMUNOLOGY (2010)
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
Wook-Jin Chae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Protumor vs Antitumor Functions of IL-17
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Overcoming Immune Evasion in T Cell Therapy of Cancer: Lessons from Animal Models
Xue-Feng Bai et al.
CURRENT MOLECULAR MEDICINE (2008)
Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells
Yongpeng Gu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Reaulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces
Yuri P. Rubtsov et al.
IMMUNITY (2008)
Contextual regulation of inflammation: A duet by transforming growth factor-beta and interleukin-10
Ming O. Li et al.
IMMUNITY (2008)
Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse
Masahito Kamanaka et al.
IMMUNITY (2006)
Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy
Xue-Feng Bai et al.
CANCER RESEARCH (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Tumor-driven evolution of immunosuppressive networks during malignant progression
Ryungsa Kim et al.
CANCER RESEARCH (2006)
Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage
A Noble et al.
BLOOD (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis
M Numasaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Interleukin-10 and the immune response against cancer: a counterpoint
S Mocellin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses
C Dercamp et al.
CANCER RESEARCH (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
AP Vicari et al.
IMMUNOLOGICAL REVIEWS (2004)
Interleukin-17 promotes angiogenesis and tumor growth
M Numasaki et al.
BLOOD (2003)
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
S Fujii et al.
BLOOD (2001)
分享论文
